These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 29559776)

  • 1. Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).
    Shevtsov M; Nikolaev B; Marchenko Y; Yakovleva L; Skvortsov N; Mazur A; Tolstoy P; Ryzhov V; Multhoff G
    Int J Nanomedicine; 2018; 13():1471-1482. PubMed ID: 29559776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor targeting using magnetic nanoparticle Hsp70 conjugate in a model of C6 glioma.
    Shevtsov MA; Yakovleva LY; Nikolaev BP; Marchenko YY; Dobrodumov AV; Onokhin KV; Onokhina YS; Selkov SA; Mikhrina AL; Guzhova IV; Martynova MG; Bystrova OA; Ischenko AM; Margulis BA
    Neuro Oncol; 2014 Jan; 16(1):38-49. PubMed ID: 24305705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors.
    Shevtsov MA; Nikolaev BP; Yakovleva LY; Marchenko YY; Dobrodumov AV; Mikhrina AL; Martynova MG; Bystrova OA; Yakovenko IV; Ischenko AM
    Int J Nanomedicine; 2014; 9():273-87. PubMed ID: 24421639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
    Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clustering superparamagnetic iron oxide nanoparticles produces organ-targeted high-contrast magnetic resonance images.
    Hobson NJ; Weng X; Siow B; Veiga C; Ashford M; Thanh NT; Schätzlein AG; Uchegbu IF
    Nanomedicine (Lond); 2019 May; 14(9):1135-1152. PubMed ID: 31050589
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparation of superparamagnetic iron oxide/doxorubicin loaded chitosan nanoparticles as a promising glioblastoma theranostic tool.
    Gholami L; Tafaghodi M; Abbasi B; Daroudi M; Kazemi Oskuee R
    J Cell Physiol; 2019 Feb; 234(2):1547-1559. PubMed ID: 30145790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High molecular weight chitosan derivative polymeric micelles encapsulating superparamagnetic iron oxide for tumor-targeted magnetic resonance imaging.
    Xiao Y; Lin ZT; Chen Y; Wang H; Deng YL; Le DE; Bin J; Li M; Liao Y; Liu Y; Jiang G; Bin J
    Int J Nanomedicine; 2015; 10():1155-72. PubMed ID: 25709439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting chemo-proton therapy on C6 cell line using superparamagnetic iron oxide nanoparticles conjugated with folate and paclitaxel.
    Kang SH; Hong SP; Kang BS
    Int J Radiat Biol; 2018 Nov; 94(11):1006-1016. PubMed ID: 30032692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant interleukin-1 receptor antagonist conjugated to superparamagnetic iron oxide nanoparticles for theranostic targeting of experimental glioblastoma.
    Shevtsov MA; Nikolaev BP; Yakovleva LY; Dobrodumov AV; Zhakhov AV; Mikhrina AL; Pitkin E; Parr MA; Rolich VI; Simbircev AS; Ischenko AM
    Neoplasia; 2015 Jan; 17(1):32-42. PubMed ID: 25622897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionizing radiation improves glioma-specific targeting of superparamagnetic iron oxide nanoparticles conjugated with cmHsp70.1 monoclonal antibodies (SPION-cmHsp70.1).
    Shevtsov MA; Nikolaev BP; Ryzhov VA; Yakovleva LY; Marchenko YY; Parr MA; Rolich VI; Mikhrina AL; Dobrodumov AV; Pitkin E; Multhoff G
    Nanoscale; 2015 Dec; 7(48):20652-64. PubMed ID: 26599206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo magnetic resonance imaging tracking of C6 glioma cells labeled with superparamagnetic iron oxide nanoparticles.
    Mamani JB; Malheiros JM; Cardoso EF; Tannús A; Silveira PH; Gamarra LF
    Einstein (Sao Paulo); 2012; 10(2):164-70. PubMed ID: 23052451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody-conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor-targeted cells and gliomas.
    Mu K; Zhang S; Ai T; Jiang J; Yao Y; Jiang L; Zhou Q; Xiang H; Zhu Y; Yang X; Zhu W
    Mol Imaging; 2015; 14():. PubMed ID: 26044549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic core-shell hybrid nanoparticles for receptor targeted anti-cancer therapy and magnetic resonance imaging.
    Shanavas A; Sasidharan S; Bahadur D; Srivastava R
    J Colloid Interface Sci; 2017 Jan; 486():112-120. PubMed ID: 27697648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
    Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
    Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Rapid Method for the Detection of Sarcosine Using SPIONs/Au/CS/SOX/NPs for Prostate Cancer Sensing.
    Uhlirova D; Stankova M; Docekalova M; Hosnedlova B; Kepinska M; Ruttkay-Nedecky B; Ruzicka J; Fernandez C; Milnerowicz H; Kizek R
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30467297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model.
    Klapproth AP; Shevtsov M; Stangl S; Li WB; Multhoff G
    Int J Nanomedicine; 2020; 15():4677-4689. PubMed ID: 32669844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-targeted polymeric micelles loaded with ultrasmall superparamagnetic iron oxide: combined small size and high MRI sensitivity.
    Hong GB; Zhou JX; Yuan RX
    Int J Nanomedicine; 2012; 7():2863-72. PubMed ID: 22745549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new class of cubic SPIONs as a dual-mode T1 and T2 contrast agent for MRI.
    Alipour A; Soran-Erdem Z; Utkur M; Sharma VK; Algin O; Saritas EU; Demir HV
    Magn Reson Imaging; 2018 Jun; 49():16-24. PubMed ID: 28958878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of ferrofluid stabilized with biocompatible chitosan and dextran sulfate hybrid biopolymer as a potential magnetic resonance imaging (MRI) T2 contrast agent.
    Tsai ZT; Tsai FY; Yang WC; Wang JF; Liu CL; Shen CR; Yen TC
    Mar Drugs; 2012 Oct; 10(11):2403-14. PubMed ID: 23203267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 70-kDa heat shock protein coated magnetic nanocarriers as a nanovaccine for induction of anti-tumor immune response in experimental glioma.
    Shevtsov MA; Nikolaev BP; Yakovleva LY; Parr MA; Marchenko YY; Eliseev I; Yudenko A; Dobrodumov AV; Zlobina O; Zhakhov A; Ischenko AM; Pitkin E; Multhoff G
    J Control Release; 2015 Dec; 220(Pt A):329-340. PubMed ID: 26522072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.